Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018; 378: 1085-1095.

Published: 17th May 2018

Authors: Choi IJ, Kook M-C, Kim Y-I, Cho S-J, Lee JY, Kim CG et al.

Conclusion

A total of 396 patients who had resection of an early gastric cancer or high grade adenoma were evaluable. At median follow-up of 5.9 years, a second gastric cancer occurred in 7.2 per cent of antibiotic treated patients versus 13.4 per cent of controls; P=0.03.

Pubmed Link

Your comments

0 Comments